» Articles » PMID: 9782033

Laparotomy and Laparoscopy Differentially Accelerate Experimental Flank Tumour Growth

Overview
Journal Br J Surg
Specialty General Surgery
Date 1998 Oct 22
PMID 9782033
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Surgery depresses host tumoricidal activity and may increase tumour growth. This study compared the effects of laparoscopy with laparotomy on extraperitoneal tumour growth and immune function in a murine model.

Methods: C57BL/6 female mice aged 8-10 weeks had tumours induced in the right flank (n=45) and were randomized to undergo halothane anaesthesia only, laparoscopy or laparotomy. Flank tumour volume was assessed over 10 days. A second group of animals (n=540) were randomized to undergo the same procedures and killed at 24, 48 and 96 h. Splenocytes were harvested for natural killer (NK) cell and lymphokine activated killer (LAK) cell cytotoxicity studies.

Results: There was a significant increase in flank tumour growth in the first 48 h after laparotomy and laparoscopy compared with controls (P < 0.01). By 96 h the difference was only significant in the laparotomy group (P< 0.01). Both NK and LAK cell cytotoxicities were suppressed significantly (P < or = 0.03) from 24 h up to 96 h following laparotomy compared with control and laparoscopy groups. There was also a significant suppression in the laparoscopy group compared with controls in the first 48 h after operation (P < or = 0.02).

Conclusion: Extraperitoneal tumour growth was significantly accelerated after laparotomy and correlated with significantly suppressed NK and LAK cytotoxicity for at least 4 days after operation. Laparoscopy had a shorter, less profound effect on tumour growth and immune function.

Citing Articles

Prognostic impact of postoperative systemic inflammatory response in patients with stage II/III gastric cancer.

Kuroda K, Toyokawa T, Miki Y, Yoshii M, Tamura T, Tanaka H Sci Rep. 2022; 12(1):3025.

PMID: 35194147 PMC: 8863782. DOI: 10.1038/s41598-022-07098-3.


Immunomodulatory Effects of Perioperative Dexmedetomidine in Ovarian Cancer: An and Xenograft Mouse Model Study.

Shin S, Kim K, Hwang H, Noh S, Oh J, Yoo Y Front Oncol. 2021; 11:722743.

PMID: 34692497 PMC: 8529066. DOI: 10.3389/fonc.2021.722743.


Surgical Stress Promotes Tumor Progression: A Focus on the Impact of the Immune Response.

Onuma A, Zhang H, Gil L, Huang H, Tsung A J Clin Med. 2020; 9(12).

PMID: 33353113 PMC: 7766515. DOI: 10.3390/jcm9124096.


Rare Treatment for a Rare Tumor: Cryoablation of a Granular Cell Tumor.

Derstine L, Soule E, Shabandi N, Arutyunova Z, Lall C, Scuderi C Gastrointest Tumors. 2020; 7(1-2):41-49.

PMID: 32399464 PMC: 7206587. DOI: 10.1159/000504134.


Combining surgery and immunotherapy: turning an immunosuppressive effect into a therapeutic opportunity.

Bakos O, Lawson C, Rouleau S, Tai L J Immunother Cancer. 2018; 6(1):86.

PMID: 30176921 PMC: 6122574. DOI: 10.1186/s40425-018-0398-7.